Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives--the adducin paradigm.

Journal of the American Society of Nephrology : JASN - 1 Apr 2006

Manunta Paolo, Bianchi Giuseppe

Abstract excerpt

There is a growing literature on the potential prospective use of genome information to enhance success in finding new medicines. An example of a prospective efficacy of pharmacogenetic and pharmacogenomics is the detection and impact of adducin polymorphism on hypertension. Adducin is a heterodimeric cytoskeleton protein, the three subunits of which are encoded by genes (ADD1, ADD2, and ADD3) that map to three...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calmodulin-Binding Proteins
Share to Cytoskeleton
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hypertension

Share to Models, Genetic

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 16565244
DOI: 10.1681/ASN.2005121346

Genes

ADD1
ADD2
ADD3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives--the adducin paradigm.PMID 16565244Read ↗

The adducin saga: pleiotropic genomic targets for precision medicine in human hypertension-vascular, renal, and cognitive diseases.Semantic proximity Read ↗

Adducin and hypertension.Semantic proximity Read ↗

A Review on Adducin from Functional to Pathological Mechanisms: Future Direction in CancerSemantic proximity Read ↗

Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: from gene polymorphism to clinical symptoms.Semantic proximity Read ↗

Characterisation and chromosomal localisation of the rat alpha- and beta-adducin-encoding genes.Semantic proximity Read ↗

Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studies.Semantic proximity Read ↗

Role of the adducin family genes in human essential hypertension.Semantic proximity Read ↗

Expression analysis of the human adducin gene family and evidence of ADD2 beta4 multiple splicing variants.Semantic proximity Read ↗

α- and β-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathySemantic proximity Read ↗

Association of the alpha-adducin locus with essential hypertension.Semantic proximity Read ↗

Alpha Adducin G460T Variant is a Risk Factor for Hypertension in Tunisian Population.Semantic proximity Read ↗

Polymorphism of gamma-adducin gene in genetic hypertension and mapping of the gene to rat chromosome 1q55.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.